Albert Seymour

Insider Reports History

Location
Bedford, MA
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Albert Seymour:

Form 4 holding President and Chief Executive Officer, Director

Homology Medicines, Inc.

Security class
Common Stock
Shares / value
150,874
Estimated value
$85,395
Report date
06 Sep 2023
Price
$0.5660
Ownership
Direct
Form 4 holding President and Chief Executive Officer, Director

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
9,380
Estimated value
$10,789
Report date
06 Sep 2023
Price
$1.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Albert Seymour

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .